CDK2 and neoplasm: Transcriptional analysis showed a marked downregulation of key genes involved in tumor cell growth and proliferation, including CDK1, CDK2, and CDK6 (up to a 31.11‐fold decrease), PLK1 (up to a 21.49‐fold decrease), and SKP2 (up to a 14.68‐fold decrease).